Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Research Report 2021

1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Overview

• 1.1 Product Overview and Scope of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
• 1.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Type
  • 1.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Live Vaccine
  • 1.2.3 Inactivated Vaccine
• 1.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Application
  • 1.3.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Comparison by Application: (2021-2027)
  • 1.3.2 Government Tender
  • 1.3.3 Marketing
• 1.4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Estimates and Forecasts
  • 1.4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue 2016-2027
  • 1.4.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales 2016-2027
  • 1.4.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Competition by Manufacturers

• 2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Sites, Area Served, Product Type
• 2.5 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Competitive Situation and Trends
  • 2.5.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Players Market Share by Revenue
  • 2.5.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Retrospective Market Scenario by Region

• 3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
  • 3.3.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
  • 3.3.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
  • 3.4.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
  • 3.4.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region
  • 3.5.2 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
  • 3.6.1 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
  • 3.6.2 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
  • 3.7.2 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Analysis by Type

• 4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2016-2021)
• 4.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2016-2021)
• 4.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2016-2021)

5 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Analysis by Application

• 5.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2016-2021)
• 5.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2016-2021)
• 5.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 CNADC
  • 6.1.1 CNADC Corporation Information
  • 6.1.2 CNADC Description and Business Overview
  • 6.1.3 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 CNADC Product Portfolio
  • 6.1.5 CNADC Recent Developments/Updates
• 6.2 Boehringer-Ingelheim
  • 6.2.1 Boehringer-Ingelheim Corporation Information
  • 6.2.2 Boehringer-Ingelheim Description and Business Overview
  • 6.2.3 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Boehringer-Ingelheim Product Portfolio
  • 6.2.5 Boehringer-Ingelheim Recent Developments/Updates
• 6.3 MSD Animal Health
  • 6.3.1 MSD Animal Health Corporation Information
  • 6.3.2 MSD Animal Health Description and Business Overview
  • 6.3.3 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 MSD Animal Health Product Portfolio
  • 6.3.5 MSD Animal Health Recent Developments/Updates
• 6.4 Sinopharm
  • 6.4.1 Sinopharm Corporation Information
  • 6.4.2 Sinopharm Description and Business Overview
  • 6.4.3 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Sinopharm Product Portfolio
  • 6.4.5 Sinopharm Recent Developments/Updates
• 6.5 Ceva
  • 6.5.1 Ceva Corporation Information
  • 6.5.2 Ceva Description and Business Overview
  • 6.5.3 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Ceva Product Portfolio
  • 6.5.5 Ceva Recent Developments/Updates
• 6.6 Chengdu Tianbang Biological Products Co., Ltd.
  • 6.6.1 Chengdu Tianbang Biological Products Co., Ltd. Corporation Information
  • 6.6.2 Chengdu Tianbang Biological Products Co., Ltd. Description and Business Overview
  • 6.6.3 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Chengdu Tianbang Biological Products Co., Ltd. Product Portfolio
  • 6.6.5 Chengdu Tianbang Biological Products Co., Ltd. Recent Developments/Updates
• 6.7 Tianjin Ruipu Biological Technology Co., Ltd.
  • 6.6.1 Tianjin Ruipu Biological Technology Co., Ltd. Corporation Information
  • 6.6.2 Tianjin Ruipu Biological Technology Co., Ltd. Description and Business Overview
  • 6.6.3 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Tianjin Ruipu Biological Technology Co., Ltd. Product Portfolio
  • 6.7.5 Tianjin Ruipu Biological Technology Co., Ltd. Recent Developments/Updates
• 6.8 Qilu Animal Health
  • 6.8.1 Qilu Animal Health Corporation Information
  • 6.8.2 Qilu Animal Health Description and Business Overview
  • 6.8.3 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Qilu Animal Health Product Portfolio
  • 6.8.5 Qilu Animal Health Recent Developments/Updates
• 6.9 Guangdong Wens Dahuanong Biotechnology Co., Ltd.
  • 6.9.1 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Corporation Information
  • 6.9.2 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Description and Business Overview
  • 6.9.3 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Product Portfolio
  • 6.9.5 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Recent Developments/Updates
• 6.10 CAVAC
  • 6.10.1 CAVAC Corporation Information
  • 6.10.2 CAVAC Description and Business Overview
  • 6.10.3 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 CAVAC Product Portfolio
  • 6.10.5 CAVAC Recent Developments/Updates
• 6.11 Komipharm
  • 6.11.1 Komipharm Corporation Information
  • 6.11.2 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
  • 6.11.3 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Komipharm Product Portfolio
  • 6.11.5 Komipharm Recent Developments/Updates
• 6.12 Agrovet
  • 6.12.1 Agrovet Corporation Information
  • 6.12.2 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
  • 6.12.3 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Agrovet Product Portfolio
  • 6.12.5 Agrovet Recent Developments/Updates
• 6.13 Bioveta
  • 6.13.1 Bioveta Corporation Information
  • 6.13.2 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
  • 6.13.3 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Bioveta Product Portfolio
  • 6.13.5 Bioveta Recent Developments/Updates
• 6.14 Jinyu Bio-Technology
  • 6.14.1 Jinyu Bio-Technology Corporation Information
  • 6.14.2 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
  • 6.14.3 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Jinyu Bio-Technology Product Portfolio
  • 6.14.5 Jinyu Bio-Technology Recent Developments/Updates
• 6.15 Phibro Animal Health
  • 6.15.1 Phibro Animal Health Corporation Information
  • 6.15.2 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
  • 6.15.3 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Phibro Animal Health Product Portfolio
  • 6.15.5 Phibro Animal Health Recent Developments/Updates
• 6.16 Tiankang
  • 6.16.1 Tiankang Corporation Information
  • 6.16.2 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
  • 6.16.3 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Tiankang Product Portfolio
  • 6.16.5 Tiankang Recent Developments/Updates
• 6.17 Zoetis
  • 6.17.1 Zoetis Corporation Information
  • 6.17.2 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
  • 6.17.3 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Zoetis Product Portfolio
  • 6.17.5 Zoetis Recent Developments/Updates
• 6.18 Guangdong Yongshun Biological Pharmaceutical Co Ltd
  • 6.18.1 Guangdong Yongshun Biological Pharmaceutical Co Ltd Corporation Information
  • 6.18.2 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
  • 6.18.3 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 Guangdong Yongshun Biological Pharmaceutical Co Ltd Product Portfolio
  • 6.18.5 Guangdong Yongshun Biological Pharmaceutical Co Ltd Recent Developments/Updates
• 6.19 Plec Bioengineering Co., Ltd.
  • 6.19.1 Plec Bioengineering Co., Ltd. Corporation Information
  • 6.19.2 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
  • 6.19.3 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
  • 6.19.4 Plec Bioengineering Co., Ltd. Product Portfolio
  • 6.19.5 Plec Bioengineering Co., Ltd. Recent Developments/Updates

7 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Cost Analysis

• 7.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
• 7.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors List
• 8.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customers

9 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Dynamics

• 9.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Trends
• 9.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Growth Drivers
• 9.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Challenges
• 9.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Restraints

10 Global Market Forecast

• 10.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Type (2022-2027)
• 10.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Application (2022-2027)
• 10.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List